HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Ohta Selected Research

Autocrine Motility Factor Receptors

3/2001Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer.
3/2001Biological characteristics of carcinomatosa pleuritis in orthotopic model systems using immune-deficient rats.
8/2000Autocrine motility factor receptor expression associates with tumor progression in thymoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Ohta Research Topics

Disease

22Neoplasms (Cancer)
11/2013 - 01/2000
10Lung Neoplasms (Lung Cancer)
06/2006 - 01/2000
7Body Weight (Weight, Body)
04/2011 - 03/2000
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2002 - 04/2000
6Heart Failure
11/2001 - 08/2000
4Hypertension (High Blood Pressure)
10/2013 - 10/2000
4Inflammation (Inflammations)
12/2009 - 07/2000
4Fibrosis (Cirrhosis)
10/2001 - 07/2000
4Heart Diseases (Heart Disease)
07/2001 - 01/2000
3Essential Hypertension
07/2013 - 06/2000
3Pleurisy (Pleuritis)
06/2006 - 03/2001
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2002 - 08/2000
3Adenocarcinoma
10/2002 - 04/2000
3Neoplasm Micrometastasis
11/2001 - 03/2001
3Myocarditis (Carditis)
10/2001 - 01/2000
3Neoplasm Metastasis (Metastasis)
07/2001 - 03/2001
2Infections
05/2019 - 07/2010
2Insulin Resistance
07/2013 - 04/2009
2Stroke (Strokes)
12/2001 - 02/2000
2MELAS Syndrome (Syndrome, MELAS)
07/2001 - 02/2000
2Carcinogenesis
06/2001 - 03/2001
2Atrial Fibrillation
04/2001 - 11/2000
2Cataract (Cataracts)
03/2001 - 08/2000
2Hepatitis C
01/2001 - 01/2000
2Tinea Pedis (Athlete's Foot)
01/2001 - 01/2000
2Tracheal Stenosis
11/2000 - 06/2000
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
08/2000 - 01/2000
2Chronic Hepatitis C
04/2000 - 01/2000
1Osteolysis
05/2019
1Dementia (Dementias)
01/2017
1Cognitive Dysfunction
01/2016
1Prion Diseases (Transmissible Spongiform Encephalopathies)
01/2016
1Dyslipidemias (Dyslipidemia)
07/2013
1Pyometra
04/2013
1Bacterial Infections (Bacterial Infection)
04/2013
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
09/2012
1Ischemic Stroke
09/2012
1Infarction (Infarctions)
09/2012
1Cerebral Infarction
09/2012
1Gliosis
12/2011

Drug/Important Bio-Agent (IBA)

10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2007 - 04/2000
4Biological ProductsIBA
11/2013 - 04/2000
4Messenger RNA (mRNA)IBA
01/2006 - 04/2000
4Pharmaceutical PreparationsIBA
10/2001 - 10/2000
3Paclitaxel (Taxol)FDA LinkGeneric
01/2011 - 01/2001
3AntioxidantsIBA
12/2009 - 08/2000
3Proteins (Proteins, Gene)FDA Link
04/2009 - 04/2000
3Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2002 - 04/2000
3MelatoninIBA
11/2001 - 03/2000
3Indicators and Reagents (Reagents)IBA
09/2001 - 01/2000
3MetallothioneinIBA
06/2001 - 01/2000
3Autocrine Motility Factor ReceptorsIBA
03/2001 - 08/2000
2Glucose (Dextrose)FDA LinkGeneric
04/2013 - 07/2001
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2005 - 07/2001
2Nitric Oxide Synthase (NO Synthase)IBA
11/2001 - 04/2000
2Interleukin-18 (Interleukin 18)IBA
10/2001 - 07/2001
2Vascular Endothelial Growth Factor CIBA
07/2001 - 04/2000
2Brain Natriuretic Peptide (Natrecor)FDA Link
07/2001 - 04/2001
2Oxygen (Dioxygen)IBA
07/2001 - 08/2000
2XenonIBA
07/2001 - 02/2000
2MetalsIBA
06/2001 - 03/2001
2Carrier Proteins (Binding Protein)IBA
06/2001 - 03/2001
2Atrial Natriuretic Factor (ANF)IBA
04/2001 - 08/2000
2Vitamin EFDA LinkGeneric
03/2001 - 08/2000
2Acetylcholine (Acetylcholine Chloride)FDA Link
03/2001 - 04/2000
2Monoclonal AntibodiesIBA
03/2001 - 08/2000
2InterferonsIBA
01/2001 - 01/2000
2NucleotidesIBA
01/2001 - 01/2000
2Carvedilol (Coreg)FDA LinkGeneric
08/2000 - 01/2000
2EnzymesIBA
08/2000 - 04/2000
1Polyethylene (Polythene)IBA
05/2019
1Codon (Codons)IBA
01/2016
1Antihypertensive Agents (Antihypertensives)IBA
10/2013
1LipidsIBA
07/2013
1BezafibrateIBA
07/2013
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
07/2013
1Fibric Acids (Fibrates)IBA
07/2013
1Mannose (D-Mannose)IBA
04/2013
1LectinsIBA
04/2013
1SugarsIBA
04/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2012
1Neuroprotective AgentsIBA
09/2012
1Tissue Plasminogen Activator (Alteplase)FDA Link
09/2012
1Fibrinolytic Agents (Antithrombotic Agents)IBA
09/2012
1Matrix Metalloproteinases (MMPs)IBA
09/2012
1PlatinumIBA
09/2012
1Atorvastatin (Lipitor)FDA Link
12/2011
1pitavastatin (itavastatin)FDA Link
12/2011
1AcetylglucosamineIBA
12/2011
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
12/2011
1CollagenIBA
12/2011

Therapy/Procedure

8Therapeutics
09/2007 - 01/2000
6Oral Administration
11/2001 - 08/2000
4Drug Therapy (Chemotherapy)
06/2006 - 02/2001
3Transplantation
08/2010 - 06/2001
2Brachytherapy
12/2004 - 01/2001
2Electric Countershock (Cardioversion)
04/2001 - 03/2001
1Debridement
05/2019
1Activities of Daily Living (ADL)
01/2017
1Intravenous Administration
09/2012